Prakt. lékáren. 2011; 7(5): 212-217 [Interní Med. 2011; 13(2): 63-69]

Intestinal microflora, mucosal barrier and probiotics in some internal diseases

Jan Lata1, Jana Juránková2
1 Interní klinika LF OU a FN Ostrava
2 Oddělení klinické mikrobiologie FN Brno

The Health Organization probiotics definition is live microorganisms which when administered in adequate amounts confer a health

benefit on the host. This review addresses the concept of intestinal microflora and their function and evidence regarding the possible

uses of probiotics in gastroenterology (diarrhoe, idiopatic bowel diseases, Helicobacter pylori infection, acute pancreatitis a prevention

of colorectal cancer) and hepatology (hepatic encephalopathy, effect on bacterial intestinal translocation and non-alcoholic

steatohepatitis).

Keywords: probiotics, gastroenterology, hepatology, intestinal microflora, colonization resistance, intestinal mucosal barrier

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lata J, Juránková J. Intestinal microflora, mucosal barrier and probiotics in some internal diseases. Praktické lékárenství. 2011;7(5):212-217.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mai V, Draganov PV. Recent advances and remaining gaps in our knowledge of assotiations between gut microbiota and human health. J Gastroenterol 2009; 15: 81-85. Go to original source...
    2. Frič P. Probiotika a prebiotika - renesance terapeutického principu. Postgraduální medicína 2005; 7(5): 472-477.
    3. McGhee JR, Strober W. Mucosal immune responses: an overview. Mucosal Immunology. San Diego: Academic Press 1999: 485-501.
    4. Verhoef-Verhage EA, Schaafsma G, et al. A guide to the intestinal microflora. Yakult Nederland B.V. In: Inside story, 1996: 11-46.
    5. Van der Waaij D, Berguist-de Vries, Lekkerkerk J. Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice. J Hyg 1972; 70(20): 335-342. Go to original source... Go to PubMed...
    6. Van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Ann Rev Microbiol 1980; 43: 69-88. Go to original source... Go to PubMed...
    7. Hooper I, Wong M, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291(5505): 881-884. Go to original source... Go to PubMed...
    8. Backhed D, Ding H, Wang T, et al. The gut microbiota as an enviromental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101(44): 19-23. Go to original source... Go to PubMed...
    9. Ley R, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proct Natl Acad Sci USA 2005; 102(31): 1107-1112. Go to original source... Go to PubMed...
    10. Guarner F, Malagelada J. Gut flora in health and disease. Lancet 2003; 361: 512-519. Go to original source... Go to PubMed...
    11. Hooper L, Gordon J. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118. Go to original source... Go to PubMed...
    12. Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 1988; 157: 1032-1037. Go to original source... Go to PubMed...
    13. Mowat A, Thomas J, MacKenzie S, et al. Divergent effect of bacterial lipopolysaccharide on imunnity to orally administered protein and particulate antigens in mice. Immunology 1986; 58: 677-683. Go to PubMed...
    14. Macpherson A, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303: 1662-1665. Go to original source... Go to PubMed...
    15. Sansonetti P. War and peace at mucosal surfaces. Nat Rev Immunol 2004; 4: 955-964. Go to original source... Go to PubMed...
    16. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995; 3(4): 149-154. Go to original source... Go to PubMed...
    17. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria (October 2001).
    18. Allen SJ. Probiotics for threating infectious diarrhoea (Cochrane Review). In: The Cochrane Library, 2004: 4. Go to original source... Go to PubMed...
    19. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers´diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 53-56. Go to original source... Go to PubMed...
    20. Hickson M, D´Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80-85. Go to original source... Go to PubMed...
    21. D´Souza AL, Rajkumar CR, Cooke J. Bulpitt Cj. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361-1364. Go to original source... Go to PubMed...
    22. Kruis W, Frič P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623. Go to original source... Go to PubMed...
    23. Mullard M, Sharratt E, Jansen C, et al. Probiotic and prebiotic use in patients with inflammatory bowel disease: A case-control study. Inflammatory Bowel Diseases 2010; 16(12): 2099-2108. Go to original source... Go to PubMed...
    24. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114. Go to original source... Go to PubMed...
    25. Kim HJ, et al. A randomized controlled trial of probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 895-904. Go to original source... Go to PubMed...
    26. Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003; 15: 313-315. Go to original source...
    27. Lamiki P, Tsuchiya J, Pathak S, et al. Probiotics in diverticular disease of the colon: an open label study. J Gastroinestin Liver Dis 2010; 19(1): 31-36.
    28. Sudu BS, Cheby HC, Kao AW, et al. Pretreatment with Lactobacillus - and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006; 83: 864-869. Go to original source... Go to PubMed...
    29. Besselink MG, Santyoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371(9613): 651-659. Go to original source... Go to PubMed...
    30. Lata J, Juránková J, Stibůrek O, et al. Probiotika u akutní pankreatitidy - randomizovaná, placebem kontrolovaná, dvojitě slepá studie. Vnitř. Lék 2010; 56(2): 111-114.
    31. Cuevas-Ramos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. PNAS 2010; 107(25): 11537-11542. Go to original source... Go to PubMed...
    32. Fotiadis C, Stoidis C, Spyropoulos BG, et al. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. J Gastroenterol 2008; 14(42): 6453-6457. Go to original source... Go to PubMed...
    33. Boča M, Vyskočil M, Mikulecký M, et al. Komplexná liečba chronickej hepatálnej encefalopatie doplnená probiotikom. Čas Lék Čes 2004; 143: 324-328.
    34. Malaguarnera M, Gargante MP, Malaguarnera G, et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol 2010; 22(2): 199-206. Go to original source... Go to PubMed...
    35. Lata J, Juránková J, Příbramská, et al. Vliv podání Escherichia coli Nissle (Mutaflor) na střevní osídlení, endotoxemii, funkční stav jater a minimální jaterní encefalopatii u nemocných s jaterní cirhózou. Vnitř. Lék 2006; 52(3): 215-220.
    36. Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010; 52(5): 1829-1835. Go to original source... Go to PubMed...
    37. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-dietinduced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-2383. Go to original source... Go to PubMed...
    38. Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database of Systematic Reviews 2007; 1: CD005165. Go to original source... Go to PubMed...
    39. Nord CE, Kager J. The normal flora of the gastrointestinal tract. Neth J med 1984; 27: 249-252.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.